A COMPARISON OF NISOLDIPINE AND NIFEDIPINE, IN COMBINATION WITH ATENOLOL, IN THE MANAGEMENT OF MYOCARDIAL-ISCHEMIA

被引:14
作者
DONALDSON, KM
DAWKINS, KD
WALLER, DG
机构
[1] SOUTHAMPTON GEN HOSP,CLIN PHARMACOL GRP,CTR BLOCK,TREMONA RD,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND
[2] SOUTHAMPTON GEN HOSP,DEPT CARDIOL,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND
关键词
NISOLDIPINE; NIFEDIPINE; ANGINA PECTORIS;
D O I
10.1093/eurheartj/14.4.534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of the addition of slow-release nifedipine 20 mg twice daily and nisoldipine 10 mg twice daily to atenolol monotherapy were compared in a double-blind placebo-controlled study of 24 patients with chronic stable angina pectoris. Neither nisoldipine nor nifedipine was associated with significant subjective benefit at these doses. Two hours post-dosing, exercise capacity improved after both nisoldipine (duration+37 s, P<0.01; time to angina+67 s, P<0.01; time to sign ST depression+60 s, P<0.01) and nifedipine (duration +21 s, ns; time to angina+56 s, P<0.05; time to significant ST depression+49 s P<0.05) However, this improvement was not maintained 12 h post-dosing. Ambulatory monitoring did not demonstrate a sign reduction in the amount of silent or total ischaemia following the addition of either nifedipine or nisoldipine to atenolol monotherapy. There was no significant difference between nifedipine and nisoldipine in any parameter tested.In conclusion, like slow-release n 20 mg, the effective duration of anti-ischaemic action of nisoldipine 10 mg is less than 12 h. Since several patients experienced vasodilatory unwanted effects, more frequent administration rather than larger individual doses may be desirable to achieve a clinical response. © 1993 The European Society of Cardiology.
引用
收藏
页码:534 / 539
页数:6
相关论文
共 22 条
[1]  
BRUGMANN U, 1984, EUROPEAN HEART J S1, V5, P274
[2]   SILENT MYOCARDIAL ISCHEMIA - A LOT AROUND BUT NOT EASY TO SUSPECT [J].
CAMPBELL, S .
BRITISH MEDICAL JOURNAL, 1988, 297 (6651) :751-752
[3]   BETA-ADRENOCEPTOR ANTAGONISTS PLUS NIFEDIPINE IN THE TREATMENT OF CHRONIC STABLE ANGINA-PECTORIS [J].
CHALLENOR, VF ;
WALLER, DG ;
GEORGE, CF .
CARDIOVASCULAR DRUGS AND THERAPY, 1989, 3 :275-285
[4]   SLOW RELEASE NIFEDIPINE PLUS ATENOLOL IN CHRONIC STABLE ANGINA-PECTORIS [J].
CHALLENOR, VF ;
WALLER, DG ;
RENWICK, AG ;
GEORGE, CF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (05) :509-516
[5]   COMPARATIVE ANTIANGINAL EFFECTS OF NISOLDIPINE AND NIFEDIPINE IN PATIENTS WITH CHRONIC STABLE ANGINA [J].
CREAN, PA ;
WATERS, DD ;
LAM, J ;
CHAITMAN, BR .
AMERICAN HEART JOURNAL, 1987, 113 (02) :261-265
[6]   SILENT MYOCARDIAL ISCHEMIA - IMPROVEMENT WITH NISOLDIPINE THERAPY [J].
GLASSER, SP ;
ARCEWESTON, B ;
CLARK, PI .
SOUTHERN MEDICAL JOURNAL, 1989, 82 (01) :32-&
[7]  
HAINS ADB, 1987, ABSTR AUSTR NZ J M S, V17, P596
[8]  
Jones B., 1989, DESIGN ANAL CROSS OV, V1st, DOI [10.4324/9780203009277, DOI 10.4324/9780203009277]
[9]  
KAZDA S, 1980, ARZNEIMITTEL-FORSCH, V30-2, P2144
[10]   A DOSE-RANGING, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL OF NISOLDIPINE IN EFFORT ANGINA - DURATION AND EXTENT OF ANTIANGINAL EFFECTS [J].
LAM, J ;
CHAITMAN, BR ;
CREAN, P ;
BLUM, R ;
WATERS, DD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (02) :447-452